We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · May 04, 2022

Comparing iRECIST-Based and Free Text Reporting of CT Scans for Monitoring Metastatic Renal Cell Carcinoma

Journal of Cancer Research and Clinical Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Cancer Research and Clinical Oncology
iRECIST-based versus non-standardized free text reporting of CT scans for monitoring metastatic renal cell carcinoma: a retrospective comparison
J. Cancer Res. Clin. Oncol. 2022 Apr 14;[EPub Ahead of Print], L Schomburg, A Malouhi, MO Grimm, M Ingwersen, S Foller, K Leucht, U Teichgräber

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading